MedTrace Logo

Prognostic Value of Isolated and Combined Score Aspects in Acute Ischemic Stroke

NCT07069452 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 152

Last updated 2025-07-16

No results posted yet for this study

Summary

This study, called TARGET-ASPECT, looks at patients who had a type of stroke called acute ischemic stroke and were treated with clot-busting medicine and a procedure to remove the clot. Even with these treatments, about half of patients don't fully recover. The study aims to see if certain brain imaging scores, especially when combined, can better predict how well patients will recover 90 days after their stroke and if their blood vessels reopen successfully. The study will include 152 patients and last about 9 months. The goal is to find easy and reliable tools that doctors can use to make better treatment decisions.

Conditions

  • Stroke, Ischemic
  • Thrombectomy
  • Thrombolytic Therapy
  • Brain Ischemia
  • Prognosis
  • Magnetic Resonance Imaging
  • Outcome Assessment (Health Care)

Sponsors & Collaborators

  • Centre Hospitalier de Gonesse

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-15
Primary Completion
2026-01-15
Completion
2026-01-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07069452 on ClinicalTrials.gov